• Profile
Close

Lisinopril vs lisinopril and losartan for mild childhood IgA nephropathy: A randomized controlled trial (JSKDC01 study)

Pediatric Nephrology Mar 22, 2019

Shima Y, et al. - Among 63 children with biopsy-proven proteinuric mild IgA nephropathy enrolled in this open-label, multicenter, prospective, and randomized phase II controlled trial, researchers compared lisinopril monotherapy to combination therapy of lisinopril and losartan, focusing on efficacy and safety. The goal was to determine a better treatment option for this patient population. They found that the two treatment options did not differ in terms of proteinuria disappearance rate (primary endpoint) in patients as well as with regard to side effects, no significant differences were found. Since combination therapy offered no advantages, they proposed lisinopril monotherapy as treatment for these patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay